Investors | Shareholder Resources
Frequently Asked Questions
What are Edesa's CUSIP and ISIN numbers?
CUSIP #: 27966L108 (as of June 7, 2019)
ISIN #: CA27966L1085 (as of June 7, 2019)
Where is Edesa's registered and records office?
Our registered and records office is:
2900 – 550 Burrard Street
Vancouver, BC V6C 0A3
Canada
Who is Edesa's transfer agent?
Computershare Investor Services Inc.
100 University Avenue
8th Floor
Toronto, Ontario M5J 2Y1
Phone: 1-800-564-6253
As background, a transfer agent for a publicly held company keeps records of stock held by registered shareholders, including shares held in certificate form. When stock changes hands, the transfer agent updates the record of ownership of the stock. The transfer agent does not maintain records of shares bought and sold through brokerage accounts and held in “street name.” Such records are maintained by the specific brokerages through which shares are bought and sold.
How do I change the address on my shareholder account?
Through your brokerage account or by contacting our transfer agent.
When will Edesa hold its annual meeting of shareholders?
The 2023 Annual Meeting of Shareholders was held on May 23, 2023. The date of the 2024 shareholders’ meeting will be announced in our future public filings.
Who are Edesa's independent auditors?
MNP LLP
111 Richmond Street West
Suite 300
Toronto , ON M5H 2G4
Who are Edesa's outside legal counsel?
Canada
Fasken Martineau DuMoulin LLP
Bay Adelaide Centre
333 Bay Street, Suite 2400
P.O. Box 20, Toronto, ON M5H 2T6
Where can I find Edesa's public reports and filings?
Edesa incorporated in Canada and is organized under the laws of British Columbia. Our common shares are traded on the U.S. Nasdaq Capital Markets (Nasdaq: EDSA). As such, Edesa files its public company reports with the U.S. Securities and Exchange Commission and the British Columbia Securities Commission.
When did Edesa go public?
Edesa went public in June 2019 through a business combination with Stellar Biotechnologies, Inc., a Nasdaq listed company. Following the business combination, Stellar changed its name to Edesa Biotech, Inc.